|
|
|
|
|
by pdabbadabba
603 days ago
|
|
> where the same problems are "simply" solved by getting on a calorie deficit and lean Except that there apparently is mounting evidence that GLP-1 agonists also address some issues that are not generally addressed by just restricting calories. TFA touches on this briefly: "The weight loss involved with GLP-1 agonist treatment is surely a big player in many of these beneficial effects, but there seem to be some pleiotropic ones beyond what one could explain by weight loss alone." I seem to recall seeing claims that they reduce COVID-19 mortality even controlling for BMI (possibly because they inhibit systemic inflammation), reduce alcohol consumption, and even (though I think just anecdotally) may help overcome gambling addiction. See, for example: https://pmc.ncbi.nlm.nih.gov/articles/PMC8425441/ [COVID-19] https://www.ncbi.nlm.nih.gov/search/research-news/19361/ [Addiction] |
|